The Mount Sinai team, known as NYC-Vita, has received a $1 million Milestone 2 award after being selected from an international field of semifinalists. XPRIZE Healthspan is a seven-year competition designed to push aging research beyond incremental improvements. Ten of those teams, including Mount Sinai, were selected as Milestone 2 Awardees and will share $10 million in direct milestone funding, with each receiving $1 million. Article Title: Mount Sinai Team Advances to XPRIZE Healthspan Finals With Immune-Aging Clinical TrialNews Publication Date: August 11, 2026Web References:https://www.mountsinai.org/about/healthspan/researchhttps://profiles.mountsinai.org/miriam-meradhttps://profiles.mountsinai.org/zahi-a-fayadhttps://profiles.mountsinai.org/fanny-m-elahihttps://profiles.mountsinai.org/thomas-u-marronhttps://profiles.icahn.mssm.edu/ryan-w-walkerhttps://www.mountsinai.org/about/executive-leadership/nestlerhttps://www.mountsinai.org/about/executive-leadership/brendan-carrReferences: XPRIZE Healthspan competition announcement; Icahn School of Medicine at Mount Sinai NYC-Vita clinical trial and Healthspan Program information. Keywords: healthy aging, healthspan, XPRIZE Healthspan, NYC-Vita, immune aging, immunosenescence, inflammaging, macrophages, clinical trial, Mount Sinai, longevity research, age-related disease, medical imaging, wearable technology, neuroscience, metabolism